GoodRx Holdings, Inc.
GDRXNASDAQHealthcareHealth Information Services
As of Oct 16, 2026 close
- Market cap
- $1.22B
- P/E (TTM)
- 75.08
- Forward P/E
- 148.52
- Dividend yield
- -
- 52-week range
- $1.77$4.30
- Volume (live)
- -
- Avg. volume (3M)
- 852.46K
GoodRx Holdings (GDRX) Stock Price & Financial Analysis
GoodRx Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.33 - $3.50 |
|---|---|
| 52-Week High | $4.30 |
| 52-Week Low | $1.77 |
| Open | $3.48 |
| Volume (last close) | 847.26K |
| Average Volume (3M) | 852.46K |
| Revenue (TTM) | 785.23M |
|---|---|
| Net Income (TTM) | 16.25M |
| Free Cash Flow (TTM) | 152.21M |
| EPS (TTM) | $0.05 |
| Profit Margin | 2.07% |
| Operating Margin | 9.54% |
| Return on Equity (ROE) | 2.51% |
| Debt to Equity | 0.75 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.22B |
|---|---|
| Shares Outstanding | 348.06M |
| P/E Ratio (TTM) | 75.08 |
| Forward P/E | 148.52 |
| Price to Sales (P/S) | 1.55 |
| Price to Book (P/B) | 1.88 |
| EV/EBITDA | 8.32 |
| 50-Day MA | $3.46 |
|---|---|
| 200-Day MA | $2.78 |
| 1-Year Change | −8.49% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
GoodRx Holdings at a Glance
As of the Oct 16, 2026 close, GoodRx Holdings (GDRX) has a market capitalization of $1.22B. The stock trades at 75.1× trailing earnings, 148.5× forward earnings and 1.6× sales. Over the trailing twelve months it earned $16.25M on revenue of $785.23M (a 2.1% profit margin) and generated $152.21M of free cash flow. Revenue fell 1.8% year over year.
As of its latest reported balance sheet, it holds $296.11M in cash and securities against $486.59M of debt, a net debt position of $190.47M.
GoodRx Holdings does not currently pay a dividend.
The share price is down 8.5% over the past year. At $3.36 (the Oct 16, 2026 close) it sits within its 52-week range of $1.77 to $4.30, above its 200-day moving average of $2.78.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $4.21, 25.3% above the Oct 16, 2026 close.
Frequently Asked Questions About GoodRx Holdings
What is the current stock price for GDRX?
As of the Oct 16, 2026 close, GDRX stock trades at $3.36. The 52-week range is $1.77–$4.30, with a day range of $3.33–$3.50.
What is the P/E ratio for GDRX?
As of the Oct 16, 2026 close, GoodRx Holdings's trailing twelve-month (TTM) P/E ratio is 75.1, meaning investors pay $75.1 for every $1 of annual earnings. The forward P/E is 148.5, reflecting analyst expectations for future earnings. GoodRx Holdings operates in the Healthcare sector.
Does GDRX pay dividends?
GoodRx Holdings does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for GDRX?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for GDRX is Hold. The average 12-month price target is $4.21, a 25.3% upside from the Oct 16, 2026 close of $3.36.
What is the market cap of GDRX?
As of the Oct 16, 2026 close, GoodRx Holdings's market capitalization is $1.17B, classifying it as a small-cap company. GoodRx Holdings operates in the Healthcare sector within the Health Information Services industry.